Akouos Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 69
Employees
  • Stock Symbol
  • AKUS
Stock Symbol
  • Share Price
  • $11.66
  • (As of Friday Closing)

Akouos General Information

Description

Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.

Contact Information

Website
www.akouos.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 645 Summer Street
  • Suite 200
  • Boston, MA 02210
  • United States
+1 (857) 000-0000

Akouos Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akouos Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.66 $12.41 $11.50 - $30.67 $402M 34.4M 135K -$12.83

Akouos Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 182,288 375,126
Revenue 0 0 0 0
EBITDA (54,222) (46,992) (25,457) (6,247)
Net Income (54,246) (48,600) (25,741) (6,013)
Total Assets 321,859 333,350 45,162 25,778
Total Debt 18,571 13,142 13,784 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Akouos Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial

Akouos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial

Akouos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearin
Drug Discovery
Boston, MA
69 As of 2020
00000
0000 0000-00-00
00000000 00000

0000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000 000000000
Boston, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akouos Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Decibel Therapeutics Formerly VC-backed Boston, MA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 00000000 Formerly VC-backed Woburn, MA 00 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Amsterdam, Netherlands 00.000 00000000000 00.000
0000000 0000000000 Venture Capital-Backed Tübingen, Germany 000.00 00000000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

Akouos Executive Team (13)

Name Title Board Seat Contact Info
Emmanuel Simons Ph.D President, Chief Executive Officer & Co-Founder
Sachiyo Minegishi Assistant Secretary, Administration & Chief Financial Officer, Finance
Jennifer Wellman Chief Operating Officer, Operations
Alan Smith Ph.D Chief Technology Officer
Morgan Molloy Chief Corporate Development Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Akouos Board Members (9)

Name Representing Role Since
Arthur Tzianabos Ph.D Self Chairman 000 0000
Chris Smith Self Board Member 000 0000
Edward Mathers New Enterprise Associates Board Member 000 0000
Heather Preston MD Self Board Member 000 0000
Kush Parmar Ph.D 5AM Ventures Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Akouos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akouos Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akouos‘s full profile, request access.

Request a free trial